Half-year report · HY
9818.TEDINET S100X39Q
Period2025-04-01 → 2025-09-30
Filed2025-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥15.0bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥33.4bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥14.8bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | ¥356m | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥344m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥403m | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.4bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥393m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥403m | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥418m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥215m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥889m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥253m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥215m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥253m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥21.6bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥22.1bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥20.9bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥6.4bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥7.2bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥15.2bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥14.9bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥14.3bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥3.3bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.2bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥3.2bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.1bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.4bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.6bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.7bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.0bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥944m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥1.4bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.7bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥670m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥184m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥858m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥438m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥28.02 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥116.15 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥33.11 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 70.4% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 67.4% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 68.7% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 24
| Segment | Item | Period | Value |
|---|---|---|---|
| Aquareportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥660m |
| Aquareportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥660m |
| Aquareportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥45m |
| Livingreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥9.9bn |
| Livingreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥9.9bn |
| Livingreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥80m |
| Medical And Industrial Gasreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥4.4bn |
| Medical And Industrial Gasreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥4.4bn |
| Medical And Industrial Gasreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥230m |
| —segment total | revenue | 2025-04-01 → 2025-09-30 | ¥15.0bn |
| —segment total | revenue external | 2025-04-01 → 2025-09-30 | ¥15.0bn |
| —segment total | segment profit | 2025-04-01 → 2025-09-30 | ¥356m |
| Aquareportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥638m |
| Aquareportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥638m |
| Aquareportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥51m |
| Livingreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥10.3bn |
| Livingreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥10.3bn |
| Livingreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥46m |
| Medical And Industrial Gasreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥3.9bn |
| Medical And Industrial Gasreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥3.9bn |
| Medical And Industrial Gasreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥247m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥14.8bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥14.8bn |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥344m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 517
| Item | Context | Value | Unit |
|---|---|---|---|
| Type1 semi annual consolidated balance sheet (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of comprehensive income single statement (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of cash flows (text) | InterimDuration | Text · Plus | |
| Major components of selling general and administrative expenses (text) | InterimDuration | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | InterimDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1InterimDuration | Text · Plus | |
| Notes regarding dividend (text) | InterimDuration | Text · Plus | |
| Notes segment information etc type1 semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1InterimDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | Prior1InterimDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | InterimDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | InterimDuration | Text · Plus | |
| Notes revenue recognition semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Notes per share information semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Notes significant events after reporting period semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | InterimDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |